RxDoctor Payments Data

Esteban Cardonne, MD

Psychiatry · Pembroke Pines, FLNPI 1962886788

Payments from drug & device makers

$1,205in general payments, 2019–2025

Across 41 payments — averaging $29.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$393
  • Teva Pharmaceuticals USA, Inc.$156
  • Kowa Pharmaceuticals America, Inc.$125
  • Eisai Inc.$122
  • Johnson & Johnson$107
  • Almatica Pharma LLC$88
  • plus $213 from 7 others

What the payments were for

  • Food & beverage$1,205100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,205 in reported general payments places this provider in the 60th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$4,923
Medicare patients
11
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clozapine14$1,869
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$837
Duloxetine Hcl64$656
Clonazepam77$557
Mirtazapine32$496
Olanzapine28$429
Memantine Hcl14$404
Buspirone Hcl17$359
Bupropion XlBupropion Hcl23$335
Venlafaxine Hcl ErVenlafaxine Hcl26$262
Risperidone23$253
Escitalopram Oxalate25$232
Trazodone Hcl37$222
Lamotrigine20$195
Quetiapine Fumarate14$176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$88$12945 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →